SCHEMBL6913

SCHEMBL6913

C#Cc1cccc(F)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29739031 1.00 — —
SCHEMBL20464789 1.00 — —
SCHEMBL11384287 0.93 TAAR1 (0.45) —
SCHEMBL3892483 0.91 GRM5 (0.44) —
SCHEMBL28061276 0.88 GRM5 (0.42) —
SCHEMBL11232059 0.88 GRM5 (0.42) —
SCHEMBL11230632 0.84 GRM5 (0.40) —
SCHEMBL11235736 0.83 GRM5 (0.39) —
SCHEMBL1502312 0.81 CA12 (0.54) —
SCHEMBL9302636 0.79 CA12 (0.62) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 951 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122059955-A Imidazo pyridone compound, photocatalysis continuous synthesis method and application thereof 南京工业大学 2026-05-19 — — CN claimed
EP-4157898-B1 CHEMICALLY CONVERTED CATALYSTS DOW GLOBAL TECHNOLOGIES LLC (US) 2026-04-29 — — EP claimed
US-20260008876-A1 ADDITIVE FOR A CATALYST DOW GLOBAL TECHNOLOGIES LLC (US) 2026-01-08 — — US claimed
WO-2025128214-A1 ADDITIVE FOR A CATALYST DOW GLOBAL TECHNOLOGIES LLC (US) 2025-06-19 — — WO claimed
WO-2025128219-A1 ADDITIVE FOR A CATALYST DOW GLOBAL TECHNOLOGIES LLC (US) 2025-06-19 — — WO claimed
WO-2025128218-A1 ADDITIVE FOR A CATALYST DOW GLOBAL TECHNOLOGIES LLC (US) 2025-06-19 — — WO claimed
WO-2025128220-A1 ADDITIVE FOR A CATALYST DOW GLOBAL TECHNOLOGIES LLC (US) 2025-06-19 — — WO claimed
WO-2025128216-A1 ADDITIVE FOR A CATALYST DOW GLOBAL TECHNOLOGIES LLC (US) 2025-06-19 — — WO claimed
WO-2025128217-A1 ADDITIVE FOR A CATALYST DOW GLOBAL TECHNOLOGIES LLC (US) 2025-06-19 — — WO claimed
CN-120132861-A Copper-based high-entropy alloy material and preparation method and application thereof 温州大学新材料与产业技术研究院 2025-06-13 — — CN claimed
CN-103299471-A Nonaqueous electrolyte for secondary battery and nonaqueous-electrolyte secondary battery MATSUSHITA ELECTRIC INDUSTRIAL CO LTD 2013-09-11 — — CN claimed
EP-2013171-B1 PIPERIDINES AND RELATED COMPOUNDS FOR TREATMENT OF ALZHEIMER S DISEASE MERCK SHARP & DOHME (GB) 2013-05-15 — — EP claimed
EP-1833791-B1 2,3,4,9-TETRAHYDRO-1H-CARBAZOLE DERIVATIVES AS CRTH2 RECEPTOR ANTAGONISTS ACTELION PHARMACEUTICALS LTD (CH) 2011-08-03 — — EP claimed
EP-1551834-B1 SUBSTITUTED QUINAZOLINONE COMPOUNDS NOVARTIS VACCINES & DIAGNOSTIC (US) 2010-08-25 — — EP claimed
EP-1599201-B1 SELECTIVE NON-STEROIDAL GLUCOCORTICOID RECEPTOR MODULATORS MERCK SHARP & DOHME (US) 2010-04-14 — — EP claimed
EP-1664027-B1 SUBSTITUTED 2,3-DIHYDRO-1H-ISOINDOL-1-ONE DERIVATIVES AND METHODS OF USE AMGEN INC (US) 2009-12-30 — — EP claimed
EP-1664023-B1 SUSTITUTED ISOQUINOLINE DERIVATIVES AND METHODS OF USE AMGEN INC (US) 2008-08-13 — — EP claimed
EP-1853595-A1 (1,5-DIPHENYL-1H-PYRAZOL-3-YL)OXADIAZOLE DERIVATIVES, PREPARATION METHOD THEREOF AND USE OF SAME IN THERAPEUTICS Sanofi-Aventis (FR) 2007-11-14 — — EP claimed
WO-2006087480-A1 (1,5-DIPHENYL-1H-PYRAZOL-3-YL)OXADIAZOLE DERIVATIVES, PREPARATION METHOD THEREOF AND USE OF SAME IN THERAPEUTICS SANOFI-AVENTIS (FR) 2006-08-24 — — WO claimed
EP-1244617-B1 SUBSTITUTED AMINOALKYLAMIDE DERIVATIVES AS ANTAGONISTS OF FOLLICLE STIMULATING HORMONE ORTHO MCNEIL PHARM INC (US) 2005-02-16 — — EP claimed
Send feedback